Department of Microbiology, Southern Illinois University, Carbondale, United States of America.
PLoS One. 2012;7(9):e46052. doi: 10.1371/journal.pone.0046052. Epub 2012 Sep 27.
Chlamydia spp. are obligate intracellular Gram-negative bacterial pathogens that cause disease in humans and animals. Minor variations in metabolic capacity between species have been causally linked to host and tissue tropisms. Analysis of the highly conserved genomes of Chlamydia spp. reveals divergence in the metabolism of the essential vitamin biotin with genes for either synthesis (bioF_2ADB) and/or transport (bioY). Streptavidin blotting confirmed the presence of a single biotinylated protein in Chlamydia. As a first step in unraveling the need for divergent biotin acquisition strategies, we examined BioY (CTL0613) from C. trachomatis 434/Bu which is annotated as an S component of the type II energy coupling-factor transporters (ECF). Type II ECFs are typically composed of a transport specific component (S) and a chromosomally unlinked energy module (AT). Intriguingly, Chlamydia lack recognizable AT modules. Using (3)H-biotin and recombinant E. coli expressing CTL0613, we demonstrated that biotin was transported with high affinity (a property of Type II ECFs previously shown to require an AT module) and capacity (apparent K(m) of 3.35 nM and V(max) of 55.1 pmol×min(-1)×mg(-1)). Since Chlamydia reside in a host derived membrane vacuole, termed an inclusion, we also sought a mechanism for transport of biotin from the cell cytoplasm into the inclusion vacuole. Immunofluorescence microscopy revealed that the mammalian sodium multivitamin transporter (SMVT), which transports lipoic acid, biotin, and pantothenic acid into cells, localizes to the inclusion. Since Chlamydia also are auxotrophic for lipoic and pantothenic acids, SMVT may be subverted by Chlamydia to move multiple essential compounds into the inclusion where BioY and another transporter(s) would be present to facilitate transport into the bacterium. Collectively, our data validates the first BioY from a pathogenic organism and describes a two-step mechanism by which Chlamydia transport biotin from the host cell into the bacterial cytoplasm.
衣原体属是专性细胞内革兰氏阴性细菌病原体,可引起人类和动物的疾病。物种间代谢能力的微小差异已被因果关系与宿主和组织嗜性联系起来。对衣原体属高度保守基因组的分析表明,必需维生素生物素的代谢发生了分歧,其基因要么用于合成(bioF_2ADB),要么用于运输(bioY)。链霉亲和素印迹法证实了衣原体中存在一种单一的生物素化蛋白。作为揭示不同生物素获取策略需求的第一步,我们研究了沙眼衣原体 434/Bu 的 BioY(CTL0613),它被注释为 II 型能量偶联因子转运体(ECF)的 S 成分。II 型 ECF 通常由一个运输特异性成分(S)和一个与染色体不相连的能量模块(AT)组成。有趣的是,衣原体缺乏可识别的 AT 模块。使用(3)H-生物素和表达 CTL0613 的重组大肠杆菌,我们证明了生物素的运输具有高亲和力(这是以前显示需要 AT 模块的 II 型 ECF 的特性)和容量(表观 K(m)为 3.35 nM,V(max)为 55.1 pmol×min(-1)×mg(-1))。由于衣原体存在于一种源自宿主的膜空泡中,称为包涵体,我们还寻求了一种将生物素从细胞质转运到包涵体空泡中的机制。免疫荧光显微镜显示,哺乳动物多维生素钠转运体(SMVT)将硫辛酸、生物素和泛酸转运到细胞内,定位于包涵体。由于衣原体也依赖硫辛酸和泛酸,SMVT 可能被衣原体劫持,将多种必需化合物转运到包涵体中,而 BioY 和另一种转运体(s)将存在于其中,以促进进入细菌的转运。总的来说,我们的数据验证了第一个来自病原体的 BioY,并描述了衣原体从宿主细胞向细菌细胞质转运生物素的两步机制。